| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9259cfa966fe620251340a003f5d6125 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2002-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2005-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ca31e1e74b056f9eb1c1a293890c75e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3327eb42dba821cb2128a779d4c8ca28 |
| publicationDate |
2005-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6958341-B2 |
| titleOfInvention |
Pyrazolopyrimidines as CRF antagonists |
| abstract |
The present invention relates to pyrazolopyrimidines according to formula (I) n n nand stereoisomers, isomers and salts thereof wherein R 1 -R 5 are selected from certain alkyl, aryl and heteroaryl species as defined in the specification wherein all of the compounds are useful as CRF antagonists and are thus useful in the treatment of neurological disorders as well as a multitude of other CRF associated diseases or conditions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8063048-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7718661-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010210642-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7446113-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006217387-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7238808-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007167460-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008300250-A1 |
| priorityDate |
1999-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |